What TV doesn't, print can't; we deliver.
What TV doesn't, print can't; we deliver.
KOLKATA: Japan has approved the booster shot of Covaxin, the anti-Covid vaccine developed by India’s Bharat Biotech, for travellers, the drug maker announced on Friday.
“We are proud to announce that Japan has approved COVAXIN booster dose for travellers. Another global recognition of the effectiveness of our universal COVID vaccine,” Bharat Biotech stated.
Earlier in April, Japan included Covaxin in the list of recognised vaccines.
“Government of Japan includes the indigenously developed and manufactured COVID-19 vaccine COVAXIN by Bharat Biotech of India, as one of the recognised vaccines for 1st and 2nd dose with effect from 10 April 2022 to further facilitate travel from India to Japan” Indian embassy in Japan tweeted on April 7.
The certificates of COVID19 vaccines that are issued outside of Japan need to fulfil certain criteria to get recognition. “If they are either in Japanese or English and contain the name, date of birth, product name or manufacturer of vaccines, vaccination date, and the number of Covid-19 vaccine doses,” the rules stated.
